Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications In both pharma and ...
Until recently structural biology has been limited by the fact that it relies on two-dimensional computer representations of three-dimensional objects. Now 3D ...
Human Papillomavirus (HPV) Simplicity Panel™ delivers a reliable, lab-ready solution for studying 14 high-risk HPV types in a streamlined research format BIRMINGHAM, Ala., Nov. 18, 2025 /PRNewswire/ - ...
In contrast, generative AI models support companies in their small molecule discovery process by enabling the simultaneous consideration of multiple complex product requirements, all while creating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback